| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Charles River Laboratories International, Inc. (CRL) has 18 insiders with recent SEC Form 4 filings, including 2 buys and 16 sells. CRL is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 210.7K | $37.95M | - | |
| COO | 65.9K | $11.88M | - | |
| VP | 27.4K | $4.94M | - | |
| VP | 27.4K | $4.93M | - | |
| CFO | 17.3K | $3.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 800 | $157.60 | $126,080.00 | -3.2% | +3.7% | - | |
| Aug 7, 2025 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 400 | $150.04 | $60,016.00 | -1.6% | +12.0% | - | |
| May 15, 2025 | Massaro George66 | Director | Sell | 140 | $137.57 | $19,260.48 | -0.8% | +11.6% | - | |
| May 14, 2025 | Massaro George66 | Director | Sell | 140 | $140.73 | $19,702.90 | -0.5% | +9.9% | - | |
| May 13, 2025 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 500 | $145.41 | $72,705.00 | -2.5% | +3.4% | - | |
| Feb 20, 2025 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 4,400 | $162.50 | $715,000.00 | -18.0% | -16.8% | +4.1% | |
| Feb 20, 2025 | Foster James C77 | Chairman, President And CEO | Buy | 6,075 | $165.01 | $1,002,435.75 | +3.4% | -16.8% | +4.1% | |
| Feb 20, 2025 | Girshick Birgit65 | Corporate Executive VP &COO | Buy | 1,514 | $164.63 | $249,249.82 | +2.8% | -16.8% | +4.1% | |
| Nov 7, 2024 | Wallman Richard F81 | Director | Sell | 7,621 | $216.17 | $1,647,418.25 | -21.4% | -21.1% | -20.1% | |
| Aug 8, 2024 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 1,780 | $199.36 | $354,860.80 | -7.3% | +6.1% | -26.3% |